Comparative effects of non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease on risk of incident cardiovascular events: a meta-analysis of about 13 million individuals

Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?

(2021) Ramy Younes et al.   GUT

Outcomes of NAFLD and MAFLD: Results from a community-based, prospective cohort study

(2021) Madunil Anuk Niriella et al.   PLoS One

Association of MAFLD with diabetes, chronic kidney disease, and cardiovascular disease: a 4.6-year cohort study in China

(2021) Yebei Liang et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States

(2021) Donghee Kim et al.   JOURNAL OF HEPATOLOGY

Metabolic Dysfunction-Associated Fatty Liver Disease Better Predicts Incident Cardiovascular Disease

(2021) Seogsong Jeong et al.   Gut and Liver

Metabolic Dysfunction-Associated Fatty Liver Disease Predicts Long-term Mortality and Cardiovascular Disease

(2021) Joon Ho Moon et al.   Gut and Liver

Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan

(2021) Masato Yoneda et al.   JOURNAL OF GASTROENTEROLOGY

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

(2020) Mohammed Eslam et al.   JOURNAL OF HEPATOLOGY

Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study

(2020) Hokyou Lee et al.   Clinical Gastroenterology and Hepatology